Skip to main content

Table 1 Mean Visual Analog Scale (VAS) and National Cancer Institute Common Toxicity Criteria for Diarrhea scores and standard deviation on day 0 and day 14 of FEC60 regimen in 10 breast cancer patients who experienced diarrhea during the FEC60 cycle

From: The effects of fluorouracil, epirubicin, and cyclophosphamide (FEC60) on the intestinal barrier function and gut peptides in breast cancer patients: an observational study

Scale Day 0 Day 14 p
VAS (0–10) 1.6 ± 0.3 3.4 ± 0.5 0.014
NCIC (0–4) 1.2 ± 0.9 1.9 ± 0.8 0.005